Early Release: Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from
by from on (#5N5NH)
ACIP reviewed information on COVID-19 vaccines and concluded that benefits of vaccination outweigh the risks of rare, serious adverse events.